Dongwha Pharm KRX:000020KOSPI

동화약품 · Korean news coverage and regulatory filings, organized.

Articles, 24h0
Articles, 7 days9
DART filings, 7 days0
Articles tracked203since Sep 11

In Q2 2026, Dongwha Pharm reported revenue of ₩137bn, up 9.5% year on year, and operating profit of ₩10.3bn. Dongwha Pharm (동화약품) appeared in 9 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 22 with 34 articles. The most common catalyst was clinical & approvals (5). It was most often mentioned alongside 글로벌테크놀로지, Medyssey and Medy-Tox.

Filing signals Dividend cut Screener

Dongwha Pharm quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩137bn+9.5%₩10.3bn
margin 7.5%
₩6.5bn
Q1 2026₩131bn+3.9%₩11.2bn
margin 8.6%
₩9.7bn
Q4 2025 derived₩124bn+2.5%−₩4.0bn
margin −3.2%
−₩1.7bn
Q3 2025₩122bn+10.7%₩1.4bn
margin 1.1%
₩242m
Q2 2025₩125bn+8.6%₩614m
margin 0.5%
₩6.1bn
Q1 2025₩126bn+5.7%₩2.3bn
margin 1.8%
−₩800m
Q4 2024 derived₩121bn+43.2%₩2.8bn
margin 2.4%
−₩1.8bn
Q3 2024₩110bn+26.0%−₩582m
margin −0.5%
−₩2.1bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Dongwha Pharm top stories 2 weeks, by number of outlets

  1. 1
    동화약품, 복합형 이상지질혈증 치료제 ‘프라바펜캡슐’ 출시
    25 outlets · 25 articlesFirst report Oct 22 09:07 메드월드뉴스
  2. 2
    동화약품, '소다활 레몬라임맛' 출시…제로 탄산음료 라인업 확대
    11 outlets · 11 articlesFirst report Oct 19 09:37 더트래커
  3. 3
    동화약품, 글로벌 인플루언서 700명에 'K.O.D' 알린다
    4 outlets · 4 articlesFirst report Oct 27 10:51 메디컬투데이글로벌테크놀로지
  4. 4
    동화제약 자회사 메디쎄이, 미국 FDA 510(k) 인증 3건 획득
    3 outlets · 3 articlesFirst report Oct 20 10:53 뉴스타운Regulatory approvalMedyssey
  5. 5
    동화약품, 산뜻한 청량감 더한 ‘소다활 레몬라임맛’ 출시
    3 outlets · 3 articlesFirst report Oct 19 10:01 메드월드뉴스
  6. 6
    동화약품, 이상지질혈증 복합제 '프라바펜캡슐' 선봬
    3 outlets · 3 articlesFirst report Oct 22 09:14 뉴스프리존

Latest Dongwha Pharm news Korean headlines